Alessia Andrea

Nov 29, 2024 | translational-medicine.biomedcentral.com | Alessia Andrea |Alessia Ricci |Gabriele Roccuzzo |Luca Bertero |Enrico Berrino |Valentina Pala | +10 more

Out of 32 patients, 15 (46.9%) were males and 17 (53.1%) were females, with a median age at diagnosis of 50 years (range: 32–80). All patients were diagnosed with stage III CM, mostly affecting the trunk (59.4%), limbs (34.4%), and head/neck (6.2%). Lymph node involvement was observed in 29/32 patients (90.6%). Basal lactate dehydrogenase (LDH) levels (normal range 250–450 UI/L) ranged from 231 to 543 UI/L in the cohort, with a median LDH level of 346 UI/L.

Nov 29, 2024 | translational-medicine.biomedcentral.com | Alessia Andrea |Alessia Ricci |Gabriele Roccuzzo |Luca Bertero |Enrico Berrino |Valentina Pala | +10 more

Out of 32 patients, 15 (46.9%) were males and 17 (53.1%) were females, with a median age at diagnosis of 50 years (range: 32–80). All patients were diagnosed with stage III CM, mostly affecting the trunk (59.4%), limbs (34.4%), and head/neck (6.2%). Lymph node involvement was observed in 29/32 patients (90.6%). Basal lactate dehydrogenase (LDH) levels (normal range 250–450 UI/L) ranged from 231 to 543 UI/L in the cohort, with a median LDH level of 346 UI/L.

Sep 18, 2023 | paperity.org | Alessia Andrea

Virchows Archiv, Sep 2023 Molecular profiling has transformed the diagnostic workflow of CNS tumors during the last years. The latest WHO classification of CNS tumors (5th edition), published in 2021, pushed forward the integration between histopathological features and molecular hallmarks to achieve reproducible and clinically relevant diagnoses.